Bigul

DIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Board of Directors at its meeting held on February 2, 2019 has decided to seek approval of shareholders by postal ballot for: 1.Re-appointment of Dr. G. Suresh Kumar (DIN: 00183128) as an Independent Director for a second term of five consecutive years 2.Re-appointment of Mr. R. Ranga Rao (DIN: 06409742) as an Independent Director for a second term of five consecutive years 3.Approval for continuance of Directorship of Mr. K. V. K. Seshavataram (DIN: 00060874), as a Non- Executive Independent Director of the Company 4.Re-appointment of Mr. K. V. K. Seshavataram (DIN: 00060874) as an Independent Director for a second term of five consecutive years notice pursuant to Section 110 of the Companies Act, 2013 along with explanatory statement is being sent to shareholders for passing of resolutions. Company is also providing e-voting facility to the shareholders to enable them to cast their vote electronically. Notice of Postal Ballot is enclosed herewith for your information and records.
14-02-2019
Bigul

Divis Laboratories' Q3 net profit rises 69% to Rs 379.49 cr; revenue up 30%

Divis Labs had reported a net profit of Rs 397.65 crore on total revenue of Rs 1,365 crore in the quarter ended September 2018
02-02-2019
Bigul

Divis Laboratories Ltd - 532488 - Outcome of Board Meeting

Board of Directors at its meeting held on Saturday, 2nd February 2019 has: 1.Approved un-audited financial results for the quarter and nine months ended 31st December, 2018. 2.Approved continuation of term of Mr. K.V.K. Seshavataram, Non-Executive Independent Director in pursuance of Regulation 17(1A) of SEBI (Listing Obligations and Disclosure Requirements)(Amendment) Regulations, 2018, as he is above 75 years of age, subject to approval of the Members. 3.Approved re-appointment of following Independent Directors for a second term of five years,subject to approval of the Members: 1.Dr. G. Suresh Kumar (commencing from 1st April, 2019);2.Mr. R. Ranga Rao (commencing from 1st April, 2019);3.Mr. K.V.K. Seshavataram (commencing from 23rd June, 2019) The Board decided to seek the approval of the Members of the Company by way of Postal Ballot in respect of items 2 & 3 above.The Board meeting commenced at 11:00 Hrs and concluded at 13:15 Hrs
02-02-2019
Bigul

Divis Laboratories Ltd - 532488 - Un-Audited Financial Results For The Quarter And Nine Months Ended 31St December, 2018

In terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following: 1. Un-audited Standalone Financial Results for the quarter and nine months ended 31st December, 2018. 2. Limited Review Report on the Standalone Financial Results 3.Press Release on the Financial Results of the Company The Board meeting commenced at 11:00 Hrs and concluded at 13:15 Hrs
02-02-2019
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Board Meeting Intimation for Approval Of Un-Audited Financial Results For Quarter And Nine Months Ended 31St December, 2018

DIVI''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2019 ,inter alia, to consider and approve un-audited financial results for the quarter and nine months ended 31st December, 2018
24-01-2019
Bigul

Divis Laboratories Ltd - 532488 - Shareholding for the Period Ended December 31, 2018

Divis Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here
09-01-2019
Bigul

Divis Laboratories Ltd - 532488 - Statement Of Investor Complaints For The Quarter Ended December 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0990 Name of the Signatory :- P.V.Lakshmi RajaniDesignation :- Company Secretary and Compliance Officer
07-01-2019
Bigul

DIVI'S LABORATORIES LTD. - 532488 - Loss of Share Certificate / Issue of Duplicate Share Certificate

Divis Laboratories Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
26-12-2018
Bigul

Transfer Of Operations Of RTA

Transfer of operations of Registrar & Share Transfer Agent from Karvy Computershare Private Limited to Karvy Fintech Private Limited pursuant to scheme of arrangement.
03-12-2018
Bigul

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Murali Krishna Prasad Divi
31-10-2018
Next Page
Close

Let's Open Free Demat Account